top of page
July 18, 2023
Advent Therapeutics awarded $3 million NIH grant for novel neonatal lung therapy - expedites development of non-invasive inhaled bronchopulmonary dysplasia therapy
In The News
July 20, 2023
Pennsylvania Biotechnology Center (PABC) 2023 Entrepreneur Spotlight - Advent Therapeutics one of three featured companies
Corporate Presentations - Publications
Presenations
Coming soon...
Publications
Gelfand CA, Sakurai R, Wang Y, Liu Y, Segal R, Rehan VK. Inhaled vitamin A is more effective than intramuscular dosing in mitigating hyperoxia-induced lung injury in a neonatal rat model of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol. 2020 Sep 1;319(3):L576-L584. doi: 10.1152/ajplung.00266.2020. Epub 2020 Aug 5. PMID: 32755324; PMCID: PMC7642870.
bottom of page